CDKN1B and cancer: Two examples of this are miR-221 and miR-222, which have been demonstrated to inhibit p27Kip1 protein expression in different cancer types, including glioblastoma, chronic lymphocytic leukemia, breast cancer and gastric cancer, determining the promotion of cancer cells growth [40,41,42,43].